JPRN-UMIN000027242已完成4 期
the effect of tofacitinib on bone mineral density in patients with rheumatoid arthritis - the effect of tofa on BMD in RA
Division of rheumatology, hiroshima clinic0 个研究点目标入组 50 人开始时间: 2017年5月3日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients had received steroids, bisphosphonates, or parathyroid hormone.
研究者
相似试验
已完成
不适用
Effects of Tocilizumab on Bone Metabolism, RANKL, osteoprotegerin, DKK-1 and osteopontin in Rheumatoid Arthritis.Rheumatoid ArthritisJPRN-UMIN000016117Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine60
进行中（未招募）
不适用
Evaluation of the effects of medication for the control of chronic Hepatitis B and its effects on bone healthC02.256.430.400Hepatitis BRBR-6f4x7pFaculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
已完成
不适用
Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT ProjectRheumatoid ArthritisNCT04175886University Hospital, Lille10
招募中
4 期
Analysis of efficacy of peficitinib in RARheumatoid arthritisJPRN-jRCTs071220070Iwamoto Naoki19
已完成
不适用
Effect on bone turnover and Bone Mineral Density (BMD) of low dose oral silicon as an adjunct to calcium/vitamin D3 in a randomised, placebo-controlled trialISRCTN57103074Bio Minerals N.V. (Belgium)184